Future Science Group
Browse
IMAGE
Supplementary figure 1.jpg (169.39 kB)
IMAGE
Supplementary figure 2.jpg (173.26 kB)
IMAGE
Supplementary figure 3.jpg (172.99 kB)
IMAGE
Supplementary figure 4.jpg (138.76 kB)
1/0
4 files

Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy. Supplementary figures

Download all (654.41 kB)
figure
posted on 2023-03-07, 08:41 authored by Xichen Zheng, Jiajie Kuai, Guanghui Shen

Supplementary figures 1-4

History

Usage metrics

    Immunotherapy

    Categories

    Keywords

    tumor vessel normalizationT cell tumor infiltrationmetronomic gemcitabineimmune checkpoint therapybreast cancer

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC